期刊文献+

外科清洁手术围手术期抗生素应用调查分析 被引量:7

Investigation and Analysis on Perioperative Antibiotics Application in Cleanness Surgical
下载PDF
导出
摘要 为研究我院外科清洁手术围手术期应用抗生素的合理性,调查了外科清洁手术病例342份,分两步评价抗生素使用的合理性:(1)有无指征应用抗生素;(2)选用的品种及给药方案是否正确、合理。结果如下:(1)有用药指征者87.7%,无用药指征者12.3%;(2)用药合理24.42%,基本合理44.1%,不合理31.48%,(90例为术后用药时间过长)。抗生素使用率98.34%;其中65.20%使用了一种抗生素,33.04%使用了两种抗生素,1.17%使用了三种抗生素,0.58%使用了三种以上抗生素。平均用药天数7.01天。我院外科清洁手术围手术期抗生素应用在用药指征、术前应用抗生素方面做得较好。存在的问题是抗生素使用起点高;术后不及时停药和药物剂量掌握不当等问题。 In order to study the rationality of the perioperative antibiotics application of cleanness surgical in our hospital, 342 cleaniness surgical cases are investigated in two aspects to evaluate the rationality of the antibiotics application. First is whether there is any indications of antibiotics application, second is whether selected variety and scheme is correct. The result showed that the ratio with antibiotics using indication is 87.7%, the ratio with no antibiotics using indication is 12.3%. Rational antibiotics application rate is 24.42%, approximate rational antibiotics application rate is 44.1%, irrational rate is 31.48%. The rate of antibiotics application is 98.34%, among them the rate of using only one antibiotic is 65.20%, the rate of using two antibiotics is 33.04%, the rate of using three antibiotics is 1.17%, the rate of using above three antibiotics is 0.58%. The average number of days is 7.01. It is concluded that antibiotics were rationally used at preoperation generally in our hospital. The problems exist in the aspects which are antibiotics using higher, antibiotics ceasing is not in time after operation, and the dosage holding.
作者 郭红 郭代红
机构地区 解放军总医院
出处 《科学技术与工程》 2006年第24期3913-3915,共3页 Science Technology and Engineering
关键词 围手术期 抗生索 清洁手术 perioperative antibiotics cleanness surgical
  • 相关文献

参考文献4

二级参考文献27

  • 1李少华.金黄色葡萄球菌生物学性状及耐药性研究[J].中华医院感染学杂志,1994,4(4):249-251. 被引量:6
  • 2潘菡清,李晓娣,于燕莉,黄萍.我院抗感染药物消耗与药敏试验现状分析[J].中国医院药学杂志,1996,16(4):153-154. 被引量:6
  • 3牛红卫,王保凤,李迪英.手术室空气消毒效果观察[J].中华医院感染学杂志,1996,6(3):161-161. 被引量:4
  • 4[1]Ferrara A, Dos-Santos C, Cimbro M. Effect of different beta-lactams in combination with beta-lactamase inhibitors in the presence or absence of tobramycin against some Enterobacteriaceae producing extended-spectrum beta-lactamases[J]. Chemotherapy,1998,44(5):313-317.
  • 5[3]Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998[J]. J Antimicrob Chemother, 2000,45(2):183-189.
  • 6[4]National Committee for Clinical Laboratory Standards. Ninth informational Supplement[S]. NCCLS document M100-S9(ISBN 1-56238-358-2).Pennsylvania:NCCLS,1999.
  • 7[6]Spanu T, Luzzaro F, Perilli M, et al. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy:implications for resistance to beta-lactams and other antimicrobial drugs[J]. Antimicrob Agents Chemother, 2002,46(1):196-202.
  • 8[7]Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases(ESBLs)[J]. Clin Microbiol Infect, 2000,6(9):460-463.
  • 9栾淑珍,刘阳,王双梅,高敏,王翠菊.450株革兰氏阴性杆菌药敏分析[J].中华医院感染学杂志,1997,7(1):51-53. 被引量:24
  • 10吕一欣,任南,徐秀华.1281 例骨科手术患者术后医院感染调查与分析[J].中华医院感染学杂志,1997,7(2):89-90. 被引量:33

共引文献131

同被引文献51

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部